The 20 Best Multicentric Castleman Disease (MCD) Doctors Near Me in Baltimore, MD

Richard Little is a Hematologist and an Oncologist practicing medicine in Bethesda, Maryland. Dr. Little is rated as a Distinguished provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Kaposi Sarcoma, Castleman Disease, Multicentric Castleman Disease (MCD), B-Cell Lymphoma, and Bone Marrow Transplant.

Edward Lee, M.D. was named one of Baltimore’s “Top Doc’s” by Baltimore Magazine in 2000 and 2002. After receiving additional training in Hematology and Medical Oncology at the University of Maryland in 1984, he remained on faculty until 1997. During his academic career, Dr. Lee was chairman of the training program for five years, started the Bone Marrow Transplant Program at the University of Maryland in 1993, and wrote 50 original articles on leukemia, lymphoma and related diseases. In 1997, Dr. Lee entered private practice as Chief of Hematology and Medical Oncology at Sinai Hospital. Practicing in Columbia since 2001, Dr. Lee treats patients with all forms of cancer, maintaining a particular interest in breast cancer, leukemia, and lymphomas. Learn more at marylandoncology.com. Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Polycythemia Vera, Paget Disease of the Breast, Breast Cancer, and Primary Lymphoma of the Brain. Dr. Lee is board certified in American Board Of Internal Medicine.

Richard F. Ambinder, M.D., Ph.D., currently serves as the James B. Murphy Professor of Oncology and the Director of the Division of Hematologic Malignancies at the Johns Hopkins Kimmel Cancer Center. He is program co-leader of the Hematologic Malignancies and Bone Marrow Transplantation Program and leads the AIDS Malignancy Consortium (AMC) site at Johns Hopkins and the AMC Translational Sciences Working Group nationally. Dr. Ambinder graduated from Harvard College with a Bachelor’s degree in biochemistry, after which he received his medical degree from the Johns Hopkins University School of Medicine before completing his residency at the Johns Hopkins Hospital. He also earned his Ph.D. in pharmacology from the Johns Hopkins University, and completed his oncology fellowship at Johns Hopkins. Within the clinic, Dr. Ambinder is active in the treatment of lymphoma and Kaposi’s sarcoma. Dr. Ambinder’s research is focused on exploring opportunities to prevent or treat cancer with viral infections. Virus-associated tumors are among the most common malignancies in certain populations and regions. For instance, Burkitt's lymphoma (EBV) and Kaposi's sarcoma (KSHV) are common in equatorial Africa, nasopharyngeal carcinoma (EBV) is common in southern Chinese populations or those with southern Chinese origins, and immunoblastic lymphomas (EBV) are common in immunocompromised patients (organ transplant recipients, AIDS patients, etc). Thus, Dr. Ambinder’s new approaches to prevention, diagnosis, and treatment stand to have a direct impact on the lives of cancer patients around the globe. Additionally, the study of how viruses can impact these tumors is important in creating model systems for the development of new approaches to cancer care. Currently, many immunotherapies target unidentified antigens, making the measurement of relevant immune responses problematic at best. However, in EBV-associated tumors the antigens are well defined, thus allowing the Ambinder lab to define the epitope-specific cellular immune responses. As a result of this breakthrough, interventions designed to alter immune response —whether they be vaccine based interventions, adoptive immunotherapy interventions, or pharmacologic interventions — may all be assessed in terms of relevant surrogate markers. Much in the same way the treatment of Hodgkin's lymphoma with radiotherapy and chemotherapy paved the way for the modern approach to cancer treatment more broadly, the treatment of EBV-associated tumors (including Hodgkin's lymphoma) may pave the way to the more generalized use of these modalities to treat a myriad of cancer types. Dr. Ambinder is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Hodgkin Lymphoma, Non-Hodgkin Lymphoma, B-Cell Lymphoma, Tissue Biopsy, and Bone Marrow Aspiration. Dr. Ambinder is board certified in American Board Of Internal Medicine.

Dr. Rakhi P. Naik is the Associate Director for the Division of Hematology at Johns Hopkins University. She also serves as Director of the Fellowship Hematology Track and Director of Organ Systems Foundation of Medicine (OSFM), the largest pre-clerkship course in the medical school. She holds an undergraduate degree in Biomedical & Electrical Engineering from Duke University, an M.D. with. Dr. Naik is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Hemolytic Anemia, and Congenital Hemolytic Anemia. Dr. Naik is board certified in American Board Of Internal Medicine.

John Wallmark is a Hematologist Oncology provider practicing medicine in Rockville, Maryland. Dr. Wallmark is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Multiple Myeloma, and Colorectal Cancer. Dr. Wallmark is board certified in American Board Of Internal Medicine.

Peter Graze is an Oncologist practicing medicine in Annapolis, Maryland. Dr. Graze is rated as an Advanced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). He is also highly rated in 69 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, and Non-Small Cell Lung Cancer (NSCLC).

Richard Schraeder is a Hematologist and an Oncologist practicing medicine in Towson, Maryland. Dr. Schraeder is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). He is also highly rated in 61 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), and Retroperitoneal Liposarcoma. Dr. Schraeder is currently accepting new patients.

Elyse Michelson is a primary care provider, practicing in Internal Medicine in Reisterstown, Maryland. Dr. Michelson is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses High Cholesterol, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Hypertension.

Bhargavi Pulluri is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Pulluri is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Schnitzler Syndrome, and Monoclonal Gammopathy of Undetermined Significance (MGUS).

Duosha Hu is a primary care provider, practicing in Internal Medicine in Silver Spring, Maryland. Dr. Hu is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). Her clinical expertise encompasses Multicentric Castleman Disease (MCD), Kaposi Sarcoma, Castleman Disease, and Sickle Cell Disease.

Justinian Ngaiza is an Oncologist practicing medicine in Salisbury, Maryland. Dr. Ngaiza is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). He is also highly rated in 90 other conditions, according to our data. His clinical expertise encompasses Von Willebrand Disease (VWD), Lung Cancer, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration.

Kevin Shannon is a Hematologist practicing medicine in Oakland, Maryland. Dr. Shannon is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Chronic Lymphocytic Leukemia (CLL), and Small Cell Lung Cancer (SCLC).

Djordje Atanackovic is a Hematologist practicing medicine in Baltimore, Maryland. Dr. Atanackovic is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, T-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Michael Streiff is a Hematologist practicing medicine in Baltimore, Maryland. Dr. Streiff is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Venous Thromboembolism (VTE), Deep Vein Thrombosis, Pulmonary Embolism, Pancreaticoduodenectomy, and Bone Marrow Aspiration.

Giovanna Tosato is a primary care provider, practicing in Internal Medicine in Bethesda, Maryland. Dr. Tosato is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Kaposi Sarcoma, Lymphoid Hyperplasia, Castleman Disease, and Multicentric Castleman Disease (MCD).

Flavio Kruter is an Oncologist practicing medicine in Westminster, Maryland. Dr. Kruter is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). He is also highly rated in 88 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Hemangioma Thrombocytopenia Syndrome, Essential Thrombocythemia, and Bone Marrow Aspiration.

Panayotis Ledakis is a Hematologist practicing medicine in Baltimore, Maryland. Dr. Ledakis is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). He is also highly rated in 79 other conditions, according to our data. His clinical expertise encompasses Appendix Cancer, Desmoplastic Small Round Cell Tumor, Anemia, Colorectal Cancer, and Ureteroscopy.

Myo Min is a Hematologist and an Oncologist practicing medicine in Bel Air, Maryland. Dr. Min is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). He is also highly rated in 78 other conditions, according to our data. His clinical expertise encompasses Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Colorectal Cancer, and Large-Cell Immunoblastic Lymphoma. Dr. Min is currently accepting new patients.

Kashif Firozvi is an Oncologist practicing medicine in Silver Spring, Maryland. Dr. Firozvi is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). He is also highly rated in 46 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Colorectal Cancer, and Familial Colorectal Cancer.

Carole Miller is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Miller is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Vaginal Cancer, Philadelphia-Negative Chronic Myeloid Leukemia, Chronic Myelogenous Leukemia (CML), and Familial Colorectal Cancer.